Current scenario and the future growth prospects of the “Cardiovascular Ultrasound System”

Major Factor Driving The Market Growth :

Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the Cardiovascular Ultrasound System Market . However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

Download PDF Brochure: http://bit.ly/2eV9fiK

The Cardiovascular Ultrasound System Market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period (2016–2021)

Key players :

Key players in the Cardiovascular Ultrasound System Market  include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

About Report :

The Cardiovascular Ultrasound System Market  is broadly segmented into test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and fetal & intracardiac echocardiogram. The stress echocardiogram segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscles and valves before and after the stress of the heart muscle.

On the basis of technology, the Cardiovascular Ultrasound System Market  is segmented into 2D, 3D & 4D, and Doppler imaging. The 2D technology is estimated to account for the largest share of the market in 2016, whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.

To Know More : http://bit.ly/2wZOVW1

Technological Advancements in Interventional Cardiology and Peripheral Vascular Devices

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog

Increasing Demand For Minimally Invasive Angioplasty Treatments Driving Global Interventional Cardiology And Peripheral Vascular Devices Market

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog 

Interventional Cardiology and Peripheral Vascular Devices Market Trends

Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. 

                                                  

On the basis of product, the interventional cardiology market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment showcase high growth potential owing to technological advancements, rising number of regulatory approvals, and increasing investments by companies to develop new devices.

Get PDF Brochure Here: http://bit.ly/2uDGzna

On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. The IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. The abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to rising incidence of smoking and hypertension.

Geographically, the interventional cardiology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements. However, the Asian market is projected to grow at the highest CAGR during the forecast period.

Key players operating in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

To Know More About It: http://bit.ly/2uE8eog